Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/14/28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
04/14/04	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
01/14/01	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/13/20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
01/13/01	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)
16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	01/01/2021
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.66%	+0.44%	+14.72%	+76.40%	4.84TCr
OTSUKA HOLDINGS CO., LTD.	+2.20%	+1.41%	+61.04%	+111.43%	3.5TCr
CIPLA LIMITED	+1.26%	-0.57%	-5.20%	+34.48%	1.16TCr
ZYDUS LIFESCIENCES LIMITED	-0.46%	-3.06%	+14.15%	+80.63%	1.15TCr
KRKA, D. D.	-0.37%	-0.37%	+37.89%	+137.78%	899.16Cr
ONO PHARMACEUTICAL CO., LTD.	+1.52%	+0.39%	+48.79%	-5.82%	687.77Cr
GEDEON RICHTER	-0.17%	-2.92%	+13.13%	+30.45%	662.25Cr
GLENMARK PHARMACEUTICALS LIMITED	-0.59%	-1.95%	+2.23%	+178.07%	642.57Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-7.92%	-13.61%	-34.97%	-4.08%	575.37Cr
Average	-0.58%	-2.72%	+16.87%	+71.04%	1.57TCr
Weighted average by Cap.	+0.08%	-1.39%	+24.98%	+81.07%

Employees

Sector